Global Genetic Virus Vector Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Genetic Virus Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Virus Vector.
The Genetic Virus Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Virus Vector market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Virus Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Virus Vector companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Genetic Virus Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Virus Vector market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Virus Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- FUJIFILM Diosynth Biotechnologies U.S.A.
- Sanofi
- Lonza
- Merck KGaA
- GENERAL ELECTRIC COMPANY
- Oxford BioMedica
- Spark Therapeutics, Inc.
- uniQure N.V.
- FinVector Vision Therapies
- Brammer Bio
- Cell and Gene Therapy Catapult
- Cobra Biologics
- REGENXBIO Inc.
- Kaneka Eurogentec S.A.
- Retroviral Vectors
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
- Other
- Gene Therapy
- Vaccinology
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Virus Vector companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Virus Vector Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Retroviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-Associated Viral Vectors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Genetic Virus Vector Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Genetic Virus Vector Market Perspective (2018-2029)
2.2 Genetic Virus Vector Growth Trends by Region
2.2.1 Global Genetic Virus Vector Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genetic Virus Vector Historic Market Size by Region (2018-2023)
2.2.3 Genetic Virus Vector Forecasted Market Size by Region (2024-2029)
2.3 Genetic Virus Vector Market Dynamics
2.3.1 Genetic Virus Vector Industry Trends
2.3.2 Genetic Virus Vector Market Drivers
2.3.3 Genetic Virus Vector Market Challenges
2.3.4 Genetic Virus Vector Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genetic Virus Vector Players by Revenue
3.1.1 Global Top Genetic Virus Vector Players by Revenue (2018-2023)
3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2018-2023)
3.2 Global Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Virus Vector Revenue
3.4 Global Genetic Virus Vector Market Concentration Ratio
3.4.1 Global Genetic Virus Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Virus Vector Revenue in 2022
3.5 Genetic Virus Vector Key Players Head office and Area Served
3.6 Key Players Genetic Virus Vector Product Solution and Service
3.7 Date of Enter into Genetic Virus Vector Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENETIC VIRUS VECTOR BREAKDOWN DATA BY TYPE
4.1 Global Genetic Virus Vector Historic Market Size by Type (2018-2023)
4.2 Global Genetic Virus Vector Forecasted Market Size by Type (2024-2029)
5 GENETIC VIRUS VECTOR BREAKDOWN DATA BY APPLICATION
5.1 Global Genetic Virus Vector Historic Market Size by Application (2018-2023)
5.2 Global Genetic Virus Vector Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Genetic Virus Vector Market Size (2018-2029)
6.2 North America Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genetic Virus Vector Market Size by Country (2018-2023)
6.4 North America Genetic Virus Vector Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Genetic Virus Vector Market Size (2018-2029)
7.2 Europe Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genetic Virus Vector Market Size by Country (2018-2023)
7.4 Europe Genetic Virus Vector Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Virus Vector Market Size (2018-2029)
8.2 Asia-Pacific Genetic Virus Vector Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genetic Virus Vector Market Size by Region (2018-2023)
8.4 Asia-Pacific Genetic Virus Vector Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Genetic Virus Vector Market Size (2018-2029)
9.2 Latin America Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genetic Virus Vector Market Size by Country (2018-2023)
9.4 Latin America Genetic Virus Vector Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Virus Vector Market Size (2018-2029)
10.2 Middle East & Africa Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genetic Virus Vector Market Size by Country (2018-2023)
10.4 Middle East & Africa Genetic Virus Vector Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 FUJIFILM Diosynth Biotechnologies U.S.A.
11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Detail
11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2018-2023)
11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Genetic Virus Vector Introduction
11.2.4 Sanofi Revenue in Genetic Virus Vector Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Genetic Virus Vector Introduction
11.3.4 Lonza Revenue in Genetic Virus Vector Business (2018-2023)
11.3.5 Lonza Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Genetic Virus Vector Introduction
11.4.4 Merck KGaA Revenue in Genetic Virus Vector Business (2018-2023)
11.4.5 Merck KGaA Recent Development
11.5 GENERAL ELECTRIC COMPANY
11.5.1 GENERAL ELECTRIC COMPANY Company Detail
11.5.2 GENERAL ELECTRIC COMPANY Business Overview
11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Introduction
11.5.4 GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2018-2023)
11.5.5 GENERAL ELECTRIC COMPANY Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Detail
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Genetic Virus Vector Introduction
11.6.4 Oxford BioMedica Revenue in Genetic Virus Vector Business (2018-2023)
11.6.5 Oxford BioMedica Recent Development
11.7 Spark Therapeutics, Inc.
11.7.1 Spark Therapeutics, Inc. Company Detail
11.7.2 Spark Therapeutics, Inc. Business Overview
11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Introduction
11.7.4 Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2018-2023)
11.7.5 Spark Therapeutics, Inc. Recent Development
11.8 uniQure N.V.
11.8.1 uniQure N.V. Company Detail
11.8.2 uniQure N.V. Business Overview
11.8.3 uniQure N.V. Genetic Virus Vector Introduction
11.8.4 uniQure N.V. Revenue in Genetic Virus Vector Business (2018-2023)
11.8.5 uniQure N.V. Recent Development
11.9 FinVector Vision Therapies
11.9.1 FinVector Vision Therapies Company Detail
11.9.2 FinVector Vision Therapies Business Overview
11.9.3 FinVector Vision Therapies Genetic Virus Vector Introduction
11.9.4 FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2018-2023)
11.9.5 FinVector Vision Therapies Recent Development
11.10 Brammer Bio
11.10.1 Brammer Bio Company Detail
11.10.2 Brammer Bio Business Overview
11.10.3 Brammer Bio Genetic Virus Vector Introduction
11.10.4 Brammer Bio Revenue in Genetic Virus Vector Business (2018-2023)
11.10.5 Brammer Bio Recent Development
11.11 Cell and Gene Therapy Catapult
11.11.1 Cell and Gene Therapy Catapult Company Detail
11.11.2 Cell and Gene Therapy Catapult Business Overview
11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Introduction
11.11.4 Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2018-2023)
11.11.5 Cell and Gene Therapy Catapult Recent Development
11.12 Cobra Biologics
11.12.1 Cobra Biologics Company Detail
11.12.2 Cobra Biologics Business Overview
11.12.3 Cobra Biologics Genetic Virus Vector Introduction
11.12.4 Cobra Biologics Revenue in Genetic Virus Vector Business (2018-2023)
11.12.5 Cobra Biologics Recent Development
11.13 REGENXBIO Inc.
11.13.1 REGENXBIO Inc. Company Detail
11.13.2 REGENXBIO Inc. Business Overview
11.13.3 REGENXBIO Inc. Genetic Virus Vector Introduction
11.13.4 REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2018-2023)
11.13.5 REGENXBIO Inc. Recent Development
11.14 Kaneka Eurogentec S.A.
11.14.1 Kaneka Eurogentec S.A. Company Detail
11.14.2 Kaneka Eurogentec S.A. Business Overview
11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Introduction
11.14.4 Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2018-2023)
11.14.5 Kaneka Eurogentec S.A. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Virus Vector Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Retroviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-Associated Viral Vectors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Genetic Virus Vector Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Genetic Virus Vector Market Perspective (2018-2029)
2.2 Genetic Virus Vector Growth Trends by Region
2.2.1 Global Genetic Virus Vector Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genetic Virus Vector Historic Market Size by Region (2018-2023)
2.2.3 Genetic Virus Vector Forecasted Market Size by Region (2024-2029)
2.3 Genetic Virus Vector Market Dynamics
2.3.1 Genetic Virus Vector Industry Trends
2.3.2 Genetic Virus Vector Market Drivers
2.3.3 Genetic Virus Vector Market Challenges
2.3.4 Genetic Virus Vector Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genetic Virus Vector Players by Revenue
3.1.1 Global Top Genetic Virus Vector Players by Revenue (2018-2023)
3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2018-2023)
3.2 Global Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Virus Vector Revenue
3.4 Global Genetic Virus Vector Market Concentration Ratio
3.4.1 Global Genetic Virus Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Virus Vector Revenue in 2022
3.5 Genetic Virus Vector Key Players Head office and Area Served
3.6 Key Players Genetic Virus Vector Product Solution and Service
3.7 Date of Enter into Genetic Virus Vector Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENETIC VIRUS VECTOR BREAKDOWN DATA BY TYPE
4.1 Global Genetic Virus Vector Historic Market Size by Type (2018-2023)
4.2 Global Genetic Virus Vector Forecasted Market Size by Type (2024-2029)
5 GENETIC VIRUS VECTOR BREAKDOWN DATA BY APPLICATION
5.1 Global Genetic Virus Vector Historic Market Size by Application (2018-2023)
5.2 Global Genetic Virus Vector Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Genetic Virus Vector Market Size (2018-2029)
6.2 North America Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genetic Virus Vector Market Size by Country (2018-2023)
6.4 North America Genetic Virus Vector Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Genetic Virus Vector Market Size (2018-2029)
7.2 Europe Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genetic Virus Vector Market Size by Country (2018-2023)
7.4 Europe Genetic Virus Vector Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Virus Vector Market Size (2018-2029)
8.2 Asia-Pacific Genetic Virus Vector Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genetic Virus Vector Market Size by Region (2018-2023)
8.4 Asia-Pacific Genetic Virus Vector Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Genetic Virus Vector Market Size (2018-2029)
9.2 Latin America Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genetic Virus Vector Market Size by Country (2018-2023)
9.4 Latin America Genetic Virus Vector Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Virus Vector Market Size (2018-2029)
10.2 Middle East & Africa Genetic Virus Vector Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genetic Virus Vector Market Size by Country (2018-2023)
10.4 Middle East & Africa Genetic Virus Vector Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 FUJIFILM Diosynth Biotechnologies U.S.A.
11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Detail
11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2018-2023)
11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Genetic Virus Vector Introduction
11.2.4 Sanofi Revenue in Genetic Virus Vector Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Genetic Virus Vector Introduction
11.3.4 Lonza Revenue in Genetic Virus Vector Business (2018-2023)
11.3.5 Lonza Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Genetic Virus Vector Introduction
11.4.4 Merck KGaA Revenue in Genetic Virus Vector Business (2018-2023)
11.4.5 Merck KGaA Recent Development
11.5 GENERAL ELECTRIC COMPANY
11.5.1 GENERAL ELECTRIC COMPANY Company Detail
11.5.2 GENERAL ELECTRIC COMPANY Business Overview
11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Introduction
11.5.4 GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2018-2023)
11.5.5 GENERAL ELECTRIC COMPANY Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Detail
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Genetic Virus Vector Introduction
11.6.4 Oxford BioMedica Revenue in Genetic Virus Vector Business (2018-2023)
11.6.5 Oxford BioMedica Recent Development
11.7 Spark Therapeutics, Inc.
11.7.1 Spark Therapeutics, Inc. Company Detail
11.7.2 Spark Therapeutics, Inc. Business Overview
11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Introduction
11.7.4 Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2018-2023)
11.7.5 Spark Therapeutics, Inc. Recent Development
11.8 uniQure N.V.
11.8.1 uniQure N.V. Company Detail
11.8.2 uniQure N.V. Business Overview
11.8.3 uniQure N.V. Genetic Virus Vector Introduction
11.8.4 uniQure N.V. Revenue in Genetic Virus Vector Business (2018-2023)
11.8.5 uniQure N.V. Recent Development
11.9 FinVector Vision Therapies
11.9.1 FinVector Vision Therapies Company Detail
11.9.2 FinVector Vision Therapies Business Overview
11.9.3 FinVector Vision Therapies Genetic Virus Vector Introduction
11.9.4 FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2018-2023)
11.9.5 FinVector Vision Therapies Recent Development
11.10 Brammer Bio
11.10.1 Brammer Bio Company Detail
11.10.2 Brammer Bio Business Overview
11.10.3 Brammer Bio Genetic Virus Vector Introduction
11.10.4 Brammer Bio Revenue in Genetic Virus Vector Business (2018-2023)
11.10.5 Brammer Bio Recent Development
11.11 Cell and Gene Therapy Catapult
11.11.1 Cell and Gene Therapy Catapult Company Detail
11.11.2 Cell and Gene Therapy Catapult Business Overview
11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Introduction
11.11.4 Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2018-2023)
11.11.5 Cell and Gene Therapy Catapult Recent Development
11.12 Cobra Biologics
11.12.1 Cobra Biologics Company Detail
11.12.2 Cobra Biologics Business Overview
11.12.3 Cobra Biologics Genetic Virus Vector Introduction
11.12.4 Cobra Biologics Revenue in Genetic Virus Vector Business (2018-2023)
11.12.5 Cobra Biologics Recent Development
11.13 REGENXBIO Inc.
11.13.1 REGENXBIO Inc. Company Detail
11.13.2 REGENXBIO Inc. Business Overview
11.13.3 REGENXBIO Inc. Genetic Virus Vector Introduction
11.13.4 REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2018-2023)
11.13.5 REGENXBIO Inc. Recent Development
11.14 Kaneka Eurogentec S.A.
11.14.1 Kaneka Eurogentec S.A. Company Detail
11.14.2 Kaneka Eurogentec S.A. Business Overview
11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Introduction
11.14.4 Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2018-2023)
11.14.5 Kaneka Eurogentec S.A. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Genetic Virus Vector Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Adenoviral Vectors
Table 4. Key Players of Adeno-Associated Viral Vectors
Table 5. Key Players of Other
Table 6. Global Genetic Virus Vector Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genetic Virus Vector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Genetic Virus Vector Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Genetic Virus Vector Market Share by Region (2018-2023)
Table 10. Global Genetic Virus Vector Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Genetic Virus Vector Market Share by Region (2024-2029)
Table 12. Genetic Virus Vector Market Trends
Table 13. Genetic Virus Vector Market Drivers
Table 14. Genetic Virus Vector Market Challenges
Table 15. Genetic Virus Vector Market Restraints
Table 16. Global Genetic Virus Vector Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Genetic Virus Vector Market Share by Players (2018-2023)
Table 18. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2022)
Table 19. Ranking of Global Top Genetic Virus Vector Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Genetic Virus Vector Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genetic Virus Vector Product Solution and Service
Table 23. Date of Enter into Genetic Virus Vector Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Virus Vector Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Genetic Virus Vector Revenue Market Share by Type (2018-2023)
Table 27. Global Genetic Virus Vector Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Genetic Virus Vector Revenue Market Share by Type (2024-2029)
Table 29. Global Genetic Virus Vector Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Genetic Virus Vector Revenue Market Share by Application (2018-2023)
Table 31. Global Genetic Virus Vector Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Genetic Virus Vector Revenue Market Share by Application (2024-2029)
Table 33. North America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Genetic Virus Vector Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Genetic Virus Vector Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Genetic Virus Vector Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 48. FUJIFILM Diosynth Biotechnologies U.S.A. Company Detail
Table 49. FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
Table 50. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product
Table 51. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 52. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Genetic Virus Vector Product
Table 56. Sanofi Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Lonza Company Detail
Table 59. Lonza Business Overview
Table 60. Lonza Genetic Virus Vector Product
Table 61. Lonza Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 62. Lonza Recent Development
Table 63. Merck KGaA Company Detail
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Genetic Virus Vector Product
Table 66. Merck KGaA Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. GENERAL ELECTRIC COMPANY Company Detail
Table 69. GENERAL ELECTRIC COMPANY Business Overview
Table 70. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product
Table 71. GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 72. GENERAL ELECTRIC COMPANY Recent Development
Table 73. Oxford BioMedica Company Detail
Table 74. Oxford BioMedica Business Overview
Table 75. Oxford BioMedica Genetic Virus Vector Product
Table 76. Oxford BioMedica Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 77. Oxford BioMedica Recent Development
Table 78. Spark Therapeutics, Inc. Company Detail
Table 79. Spark Therapeutics, Inc. Business Overview
Table 80. Spark Therapeutics, Inc. Genetic Virus Vector Product
Table 81. Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 82. Spark Therapeutics, Inc. Recent Development
Table 83. uniQure N.V. Company Detail
Table 84. uniQure N.V. Business Overview
Table 85. uniQure N.V. Genetic Virus Vector Product
Table 86. uniQure N.V. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 87. uniQure N.V. Recent Development
Table 88. FinVector Vision Therapies Company Detail
Table 89. FinVector Vision Therapies Business Overview
Table 90. FinVector Vision Therapies Genetic Virus Vector Product
Table 91. FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 92. FinVector Vision Therapies Recent Development
Table 93. Brammer Bio Company Detail
Table 94. Brammer Bio Business Overview
Table 95. Brammer Bio Genetic Virus Vector Product
Table 96. Brammer Bio Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 97. Brammer Bio Recent Development
Table 98. Cell and Gene Therapy Catapult Company Detail
Table 99. Cell and Gene Therapy Catapult Business Overview
Table 100. Cell and Gene Therapy Catapult Genetic Virus Vector Product
Table 101. Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 102. Cell and Gene Therapy Catapult Recent Development
Table 103. Cobra Biologics Company Detail
Table 104. Cobra Biologics Business Overview
Table 105. Cobra Biologics Genetic Virus Vector Product
Table 106. Cobra Biologics Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 107. Cobra Biologics Recent Development
Table 108. REGENXBIO Inc. Company Detail
Table 109. REGENXBIO Inc. Business Overview
Table 110. REGENXBIO Inc. Genetic Virus Vector Product
Table 111. REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 112. REGENXBIO Inc. Recent Development
Table 113. Kaneka Eurogentec S.A. Company Detail
Table 114. Kaneka Eurogentec S.A. Business Overview
Table 115. Kaneka Eurogentec S.A. Genetic Virus Vector Product
Table 116. Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 117. Kaneka Eurogentec S.A. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 1. Global Genetic Virus Vector Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Adenoviral Vectors
Table 4. Key Players of Adeno-Associated Viral Vectors
Table 5. Key Players of Other
Table 6. Global Genetic Virus Vector Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genetic Virus Vector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Genetic Virus Vector Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Genetic Virus Vector Market Share by Region (2018-2023)
Table 10. Global Genetic Virus Vector Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Genetic Virus Vector Market Share by Region (2024-2029)
Table 12. Genetic Virus Vector Market Trends
Table 13. Genetic Virus Vector Market Drivers
Table 14. Genetic Virus Vector Market Challenges
Table 15. Genetic Virus Vector Market Restraints
Table 16. Global Genetic Virus Vector Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Genetic Virus Vector Market Share by Players (2018-2023)
Table 18. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2022)
Table 19. Ranking of Global Top Genetic Virus Vector Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Genetic Virus Vector Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genetic Virus Vector Product Solution and Service
Table 23. Date of Enter into Genetic Virus Vector Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Virus Vector Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Genetic Virus Vector Revenue Market Share by Type (2018-2023)
Table 27. Global Genetic Virus Vector Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Genetic Virus Vector Revenue Market Share by Type (2024-2029)
Table 29. Global Genetic Virus Vector Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Genetic Virus Vector Revenue Market Share by Application (2018-2023)
Table 31. Global Genetic Virus Vector Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Genetic Virus Vector Revenue Market Share by Application (2024-2029)
Table 33. North America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Genetic Virus Vector Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Genetic Virus Vector Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Genetic Virus Vector Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Genetic Virus Vector Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Genetic Virus Vector Market Size by Country (2024-2029) & (US$ Million)
Table 48. FUJIFILM Diosynth Biotechnologies U.S.A. Company Detail
Table 49. FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
Table 50. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product
Table 51. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 52. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Genetic Virus Vector Product
Table 56. Sanofi Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Lonza Company Detail
Table 59. Lonza Business Overview
Table 60. Lonza Genetic Virus Vector Product
Table 61. Lonza Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 62. Lonza Recent Development
Table 63. Merck KGaA Company Detail
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Genetic Virus Vector Product
Table 66. Merck KGaA Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. GENERAL ELECTRIC COMPANY Company Detail
Table 69. GENERAL ELECTRIC COMPANY Business Overview
Table 70. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product
Table 71. GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 72. GENERAL ELECTRIC COMPANY Recent Development
Table 73. Oxford BioMedica Company Detail
Table 74. Oxford BioMedica Business Overview
Table 75. Oxford BioMedica Genetic Virus Vector Product
Table 76. Oxford BioMedica Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 77. Oxford BioMedica Recent Development
Table 78. Spark Therapeutics, Inc. Company Detail
Table 79. Spark Therapeutics, Inc. Business Overview
Table 80. Spark Therapeutics, Inc. Genetic Virus Vector Product
Table 81. Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 82. Spark Therapeutics, Inc. Recent Development
Table 83. uniQure N.V. Company Detail
Table 84. uniQure N.V. Business Overview
Table 85. uniQure N.V. Genetic Virus Vector Product
Table 86. uniQure N.V. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 87. uniQure N.V. Recent Development
Table 88. FinVector Vision Therapies Company Detail
Table 89. FinVector Vision Therapies Business Overview
Table 90. FinVector Vision Therapies Genetic Virus Vector Product
Table 91. FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 92. FinVector Vision Therapies Recent Development
Table 93. Brammer Bio Company Detail
Table 94. Brammer Bio Business Overview
Table 95. Brammer Bio Genetic Virus Vector Product
Table 96. Brammer Bio Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 97. Brammer Bio Recent Development
Table 98. Cell and Gene Therapy Catapult Company Detail
Table 99. Cell and Gene Therapy Catapult Business Overview
Table 100. Cell and Gene Therapy Catapult Genetic Virus Vector Product
Table 101. Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 102. Cell and Gene Therapy Catapult Recent Development
Table 103. Cobra Biologics Company Detail
Table 104. Cobra Biologics Business Overview
Table 105. Cobra Biologics Genetic Virus Vector Product
Table 106. Cobra Biologics Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 107. Cobra Biologics Recent Development
Table 108. REGENXBIO Inc. Company Detail
Table 109. REGENXBIO Inc. Business Overview
Table 110. REGENXBIO Inc. Genetic Virus Vector Product
Table 111. REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 112. REGENXBIO Inc. Recent Development
Table 113. Kaneka Eurogentec S.A. Company Detail
Table 114. Kaneka Eurogentec S.A. Business Overview
Table 115. Kaneka Eurogentec S.A. Genetic Virus Vector Product
Table 116. Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2018-2023) & (US$ Million)
Table 117. Kaneka Eurogentec S.A. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Genetic Virus Vector Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Genetic Virus Vector Market Share by Type: 2022 VS 2029
Figure 3. Retroviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-Associated Viral Vectors Features
Figure 6. Other Features
Figure 7. Global Genetic Virus Vector Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Genetic Virus Vector Market Share by Application: 2022 VS 2029
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccinology Case Studies
Figure 11. Genetic Virus Vector Report Years Considered
Figure 12. Global Genetic Virus Vector Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Genetic Virus Vector Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Genetic Virus Vector Market Share by Region: 2022 VS 2029
Figure 15. Global Genetic Virus Vector Market Share by Players in 2022
Figure 16. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Genetic Virus Vector Revenue in 2022
Figure 18. North America Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Genetic Virus Vector Market Share by Country (2018-2029)
Figure 20. United States Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Genetic Virus Vector Market Share by Country (2018-2029)
Figure 24. Germany Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Genetic Virus Vector Market Share by Region (2018-2029)
Figure 32. China Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Genetic Virus Vector Market Share by Country (2018-2029)
Figure 40. Mexico Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Genetic Virus Vector Market Share by Country (2018-2029)
Figure 44. Turkey Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 48. Lonza Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 49. Merck KGaA Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 50. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 51. Oxford BioMedica Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 52. Spark Therapeutics, Inc. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 53. uniQure N.V. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 54. FinVector Vision Therapies Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 55. Brammer Bio Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 56. Cell and Gene Therapy Catapult Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 57. Cobra Biologics Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 58. REGENXBIO Inc. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 59. Kaneka Eurogentec S.A. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Figure 1. Global Genetic Virus Vector Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Genetic Virus Vector Market Share by Type: 2022 VS 2029
Figure 3. Retroviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-Associated Viral Vectors Features
Figure 6. Other Features
Figure 7. Global Genetic Virus Vector Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Genetic Virus Vector Market Share by Application: 2022 VS 2029
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccinology Case Studies
Figure 11. Genetic Virus Vector Report Years Considered
Figure 12. Global Genetic Virus Vector Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Genetic Virus Vector Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Genetic Virus Vector Market Share by Region: 2022 VS 2029
Figure 15. Global Genetic Virus Vector Market Share by Players in 2022
Figure 16. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Genetic Virus Vector Revenue in 2022
Figure 18. North America Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Genetic Virus Vector Market Share by Country (2018-2029)
Figure 20. United States Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Genetic Virus Vector Market Share by Country (2018-2029)
Figure 24. Germany Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Genetic Virus Vector Market Share by Region (2018-2029)
Figure 32. China Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Genetic Virus Vector Market Share by Country (2018-2029)
Figure 40. Mexico Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Genetic Virus Vector Market Share by Country (2018-2029)
Figure 44. Turkey Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Genetic Virus Vector Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 48. Lonza Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 49. Merck KGaA Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 50. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 51. Oxford BioMedica Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 52. Spark Therapeutics, Inc. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 53. uniQure N.V. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 54. FinVector Vision Therapies Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 55. Brammer Bio Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 56. Cell and Gene Therapy Catapult Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 57. Cobra Biologics Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 58. REGENXBIO Inc. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 59. Kaneka Eurogentec S.A. Revenue Growth Rate in Genetic Virus Vector Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
